The expression of ANXA1, ANXA2, ANXA3, ANXA5, ANXA6, ANXA8, and ANXA13 was closely related to basal-subtype bladder cancer, while the expression of ANXA4, ANXA9, ANXA10, and ANXA11 was closely related to luminal-subtype BC. Here, ANXA4 is linked to urinary bladder carcinoma.